top of page
Bacteria Cells with Overlay.jpg

PIPELINE

Discover our pipeline of therapeutics designed to tackle critical healthcare challenges and improve lives. 

Pipeline Slide - September 2025_edited.jpg

Improving lives fuels our motivation.

Discovery research and preclinical development are core to our purpose of providing pioneering innovations.  By harnessing the science within the intricate network of the nucleic acidome that governs replication, gene expression, and cellular function and signaling, we can discover and develop transformative medicines to improve people’s overall health.

Walking Man with Cell Overlay.jpg
Artboard 1.jpg

Countermeasures Against Resistance.

Our current antibiotic program is focused on the discovery and preclinical development of small molecules that interfere at multiple points in the flow of genetic information within bacteria.  This approach will allow us to develop broadly active antibiotics against both Gram-positive and Gram-negative bacteria.  Furthermore, we will be able to address the growing threat of bacterial antimicrobial resistance with our novel antibiotic pipeline.

Want to Chat About
Our Pipeline?

Fill out the form below to get started.

Thanks for submitting - we'll get back to you asap.

Blue Sky Logo Cloud_Full Color Logo Set BSP.png

Tel: +353 87 330 1590

Ardee, Co. Louth

Ireland

OUR MISSION

Founded in 2024 out of a desire to save the world’s most vulnerable from the threat of treatment-resistant infections, our mission is to develop pioneering therapies that combat the most pressing infectious disease needs as well as debilitating inflammatory diseases and cancer, ensuring safe and effective treatments are accessible worldwide to improve the lives of patients for generations to come.

  • LinkedIn_BSP_LinkedIn_Pink

© 2025 Blue Sky Pharmaceuticals LTD. 

SUBSCRIBE

Sign up to receive Blue Sky Pharma news and updates.

bottom of page